Saturday 17 October 2026
Export MDCX’s income statement to Excel — free account
Medicus Pharma Ltd
MDCX Healthcare Drug Manufacturers General
In the quarter to June 2026, EPS grew 51.2% and free cash flow fell 27.7%, each against the same quarter a year earlier.
3.27
0.16
−4.66%
Follow MDCX
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
1.57 | 1.22 | 1.00 | 0.92 |
+8 more quarters Free account |
Net Debt/EBITDA |
(0.24) | 0.74 | 1.12 | 0.56 | |
Debt/Assets |
66.32% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
(10.42) | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.61 | 0.97 | 0.44 | 0.32 | |
Interest Coverage |
(55.83) | — | — | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.13) | (0.30) | (0.38) | (0.36) | |
Cash per Share |
0.28 | 0.22 | 0.50 | 0.46 | |
Shareholders Equity per Share |
(0.03) | 0.05 | 0.00 | (0.04) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.03) | 0.05 | 0.00 | (0.04) | |
Free Cash Flow |
(6.98) | (8.97) | (6.61) | (6.76) | |
Working Capital |
6.14 | 1.33 | (0.05) | (0.88) | |
Net Current Asset Value |
(11.86) | 1.28 | (0.13) | (1.00) | |
| Other line items | |||||
Quick Ratio |
1.40 | 1.07 | 0.88 | 0.81 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.13) | (0.30) | (0.38) | (0.36) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
4.25 | 2.16 | 2.36 | 1.95 | |
Average Assets |
19.53 | 6.54 | 7.85 | 7.85 | |
Average Common Equity |
0.76 | 1.79 | 1.59 | 1.34 |
Columns are period end dates